COVID In the News

BIO has pivoted to keep members, government officials, and the public informed on industry efforts related to coronavirus. Find relevant letters and comments, statements, and news hits below.

BIO Sends Letter to HHS Secretary Alex Azar

On October 1, Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a letter on urging Health and Human Services (HHS) Secretary Alex Azar to “publicly release all new guidance developed by the Food and Drug Administration (FDA) concerning emergency use authorization for vaccines to prevent the spread of COVID-19.”

Read Letter

An Open Letter to the Biopharmaceutical Industry

On September 3, BIO released an open letter to their biopharmaceutical colleagues that articulates key principles to ensure the “integrity, transparency, and objective assessment” of Covid-19 clinical data and secure public trust in new medical products developed in response to the pandemic.

Read the Letter

VIEW ALL LETTERS & PRESS RELEASES

In the News

Why you should be reassured about COVID-19 vaccine trials

Experts say securing a COVID vaccine in record time could be easy. Distributing it won't be.

The Speed of Science

VIEW ALL

The Fight Against COVID-19

The Coronavirus is No Match For Science and Collaboration. See all of BIO's COVID resources and learn about the unprecedented scientific effort to combat the virus.

Learn More

Good Day BIO Newsletter

Good Day BIO, the only daily newsletter at the intersection of biotech, politics, and policy. Subscribe to get it delivered to your inbox every weekday at 10 AM ET—and stay ahead of the news of the day.

Subscribe Now!

View the Entire Good Day BIO Archive

Follow @IAmBiotech on Twitter